Home › Studies › PRJDB41627
PRJDB41627 DRP018595

GLP-1 agonist vs dietary fiber in overweight/obese adults

GLP-1 RAs or dietary fiber interventions study (PRJCA050830)

112 samples from an open-label, multi-centered clinical trial comparing GLP-1 receptor agonist (semaglutide) and high dietary fiber interventions in overweight or obese subjects; related mouse FMT and dietary experiments were also conducted. machine-written summary

142 samples · 217 runs · Age unknown · 2026 · 10.17 Gbp / sample

Sources
✓Sequence archive 142✓Abstract / description 142–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive142 sample values (collection date)
✓ Abstract / description142 sample values (health condition detail)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Non-antibiotic pharmaceutical given as the study intervention (metformin Prebiotic / dietary fibre supplement design randomized_controlled_trial · population obesity · Semaglutide (GLP-1 RA) vs high dietary fiber in obese subjects; FMT to germ-free mice

“GLP-1 receptor agonists or high dietary fiber interventions study” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
Age
unknown142
Body site
primary142
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 4 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 26 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 112 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 11.20 Gbp per sample0130Gbp
Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country0 0%
health_condition0 0%
subject_id0 0%
collection_date142 100%142
health_condition_detail142 100%142
Papers (1)
  • GLP-1 RA-Exacerbated Gut Microbiome Dysbiosis in Obesity Mediates Post-Cessation Weight Regain 2026 own_data
Details
Archive description

The GLP-1 receptor agonists or high dietary fiber interventions study is an open-label, multi-centered clinical trial in subjects with overweight or obese. FMT animal trial: The six-week-old germ-free male mice (C57BL/6J) were given oral gavage (3 times/week) with a 200-�l fecal slurry for 2 weeks. Mice were randomly divided into two groups: mW and mG groups (n=15 per group) inoculated with the fecal slurry of two donors who are from W (dietary fiber intervention) and G (semaglutide intervention) groups, respectively. Semaglutide and dietary fiber interventions animal trial: The eight-week-old SPF male mice (C57BL/6J) were fed western style diet (D12079B, SYSE Bio-tech. Co., Ltd., China) for 4 weeks to construct diet-induced obesity (DIO) model, then performed once every three days subcutaneous injection with semaglutide (0.1 mg/kg body weight, GWSD group) or semaglutide and oral gavage of dietary fiber (500 mg/kg bodyweight/day, WGWSD group) or normal saline as control (CWSD group) for 4 weeks. After the intervention, the mice of GWSD group and WGWSD group were fed normal chow diet (AIN-93G, SYSE Bio-tech. Co., Ltd., China) for 3 weeks as GNC group and WGNC group, respectively.

How this project entered the registry

Classified as human and non-human (mixed) gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.40. Assay shotgun_dna.

  • host study.description · “clinical trial in subjects with overweight or obese”
  • host study.description · “germ-free male mice (C57BL/6J)”
  • body site study.description · “200-�l fecal slurry”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMD01844202collection_date2023-01-13R10.90biosample.attribute:collection_date2023-01-13
SAMD01844202health_condition_detailmixed_case_control: dietary fiber vs semaglutide intervention groupsR40.50study.descriptionsubjects with overweight or obese
Sequencing

217 runs over 142 samples · mean 7.12 Gbp per run (median 10.17 Gbp, total 1,544.49 Gbp; 217 runs with a base count) · layout PAIRED 217 · platform ILLUMINA 217 · models Illumina NovaSeq 6000 (138), Illumina HiSeq 2000 (79) · 0% of runs with a Sandpiper profile · first public 2026-06-02

Authors (0)

No author record.

Help complete this project

4 of the 4 core fields are below 50% coverage: age_category, country, health_condition, subject_id. Share metadata

Downloads

PRJDB41627.csv.gz (4.3 KB) · parquet (74.4 KB) — all 142 samples, every field with route and confidence · PRJDB41627_determinations.csv.gz (2.5 KB) — 284 evidence rows

Samples (142 · every field this project has values for · hover a cell for its source)
Loading the sample table…